Our focus remains, as it has for nearly three decades, on patient and donor safety, and the safety of therapies derived from plasma.
Created on April 03 2020.
PPTA Statement on FDA Guidance Documents
PPTA is aware of the guidance documents released by the U.S. Food and Drug Administration on April 2 regarding Source plasma donor eligibility and is currently evaluating them.